FDA Investigator Corrine M Carter

Corrine M Carter has conducted inspections on 132 sites in 3 countries as of 25 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
132
Last Inspection Date:
25 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Denmark, Canada
FDA Investigators that have inspected at least one site in common with Corrine M Carter:
Akbar J Zaidi, Alanna L Mussawwir Bias, Amanda L Baskin, Andrace L Deyampert, Andrea A Branche, Andrea D Swingle, Andrew H Paeng, Angel S Johnson, Anthony R Petriella, Anya Dlockett Evans, Ava M Bowman, Azza Talaat, Barbara A Rusin, Bei Y He, Benjamin J Smith, Brandi N Mcgrady, Brian D Garthwaite, Brian M Campbell, Brittany M Lowe, Byungja E Marciante, Calvin K Cook, Camille D Brown, Carmen M Faraianu, Caroline H Le, Catherine V Quinlan, CDR Kimberly Y Martin, Charles D Brown, Charles I Ann, Charles L Zhou, Charles M Spyr, Chelsea W Lamm, Cheron M Portee, Cheryl A Fuhs, Cheryl M Monroe, Constantin Y Philopoulos, Cynthia L Aycock, Cynthia Li, Daniel B Bordt, Daniel J Gorski, Danny Tuntevski, Darren S Morgan, David A Paterson, David L Duncan, David Perkins, Dawn C Olenjack, Debara R Reese, Debara Reese, Denise L Burosh, Dennis E Guilfoyle, PhD, Dennis R Downer, Dina A Tallman, Donald C Obenhuber, PhD, Dr. Abhijit Raha, PhD, Edwardstine J Reese, Elisa M Fleming, Elizabeth D Connell, Emest F Bizjak, Emily J Orban, Eric S Pittman, Eric Zhu, Etty Feller, Everard A Irish, Geneve M Maxwell, Geoffrey K Kilili, Habacuc V Barrera, Helen B Ricalde, Ifueko Osemwota, James A Lane, James H Robinson, Janice M Hickok, Jasmine Y Wang, Jean Blackston Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer R Johnson, Joel D Martinez, Johann M Fitch, Joie A Navarrete, Jorge F Christian, Joris Vanloco, Joseph A Piechocki, Joseph R Strelnik, Juliane C Lessard, Karen M Montgomery (KMM), Kathryn Suttling, Kelley L Clark, Kennita Riddick, Kimberly A Dux, Kinh Q Mac, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Laureen M Geniusz, Lauren E Burke, Lauren E Sexton, Lauren Iacono Connors, PhD, LCDR Anastasia M Piliafas Brown, Leigh Anne Myers, Lesley Maep Lutao, Leslie A Paul, Lewis K Antwi, Lisa M Bellows, Lisa P Oakes, Lloyd D Payne, Lorenzo Jones, Luella J Rossi, Lynda L Lanning, Maira P Brading, Margaret M Annes, Mark G Peterson, Martha Sullivan Myrick, Martin R Vowell, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Mercy Oyugi, Merelynn Rhoten, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michelle L Jones, Monica J Wilkins, Monique S Frazier, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy A Bellamy, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nicole C Victoria, PhD, Norman Wong, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patsy J Domingo, Paula J Perry, Phillip D Waldron, Qiao Y Bobo, Rabin N Ghoshal, Rafeeq A Habeeb, Ralph A Erickson, Raymond T Oji, Rebecca E Dombrowski, Regina T Brown, Robert D Tollefsen, Robert G Taylor, Robert J Ham, Robert M Barbosa, Samson O Oluseye, Sandra A Boyd, Sandra A Hughes, Sandy J Ziegler, Sarah M Meng, Sarah M Napier, Scott B Laufenberg, Sherri J Jackson, Sherrie L Krolczyk, Sidney B Priesmeyer, Stephanie Barragan, Stephanie Mangigian, MS/OSH, RN, Susan F Laska, MS, Susan P Bruederle, Suyang Qin, Terri E Gibson, Theodore N Sietsema, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy C Schell, Tina M Pawlowski, Tracey Asinjen Wiersma, Travis M Beard, Travis S Bradley, Veronica L Bush, Wayne E Seifert, William D Tingley, William G Nelson, William R Brubaker, Yangmin Ning, Yumi J Hiramine

Corrine M Carter's Documents

Publish Date Document Type Title
August, 2022 FDA 483 Labcorp Drug Development Inc. - Form 483, 2022-08-12
September, 2015 FDA 483 Response Dr. Mahendra Sanapati, MD - Form 483R, 2016-01-18
December, 2023 FDA 483 Leslie H. Lundahl, PhD - Form 483, 2023-12-15
August, 2022 EIR Labcorp Drug Development Inc. - EIR, 2023-11-06
August, 2018 FDA 483 Inotiv, Inc - Form 483, 2018-08-03
November, 2016 FDA 483 David C. Delgado, M.D. - Form 483, 2016-11-03
July, 2015 FDA 483 Response Med-Mizer, Inc. - Form 483R, 2015-07-20
October, 2020 FDA 483 Joseph Thaddeus Beck, MD - Form 483, 2020-10-02
July, 2016 EIR David A. Plager, M.D. - EIR, 2016-07-27
September, 2015 EIR Dr. Mahendra Sanapati, MD - EIR, 2015-09-18
December, 2015 FDA 483 Cindy M. Basinski, MD - Form 483, 2015-12-03
August, 2023 FDA 483 Miguelangelo J. Perez-Cruet, M.D., M.S. - Form 483, 2023-08-25
May, 2019 FDA 483 Shadia I. Jalal, M.D. - Form 483, 2019-05-17
July, 2016 FDA 483 Response David A. Plager, M.D. - Form 483R, 2016-08-12
September, 2017 FDA 483 Jeffrey Kline - Form 483, 2017-09-06
September, 2015 FDA 483 Dr. Mahendra Sanapati, MD - Form 483, 2015-09-18
February, 2019 FDA 483 Franciscan Health IRB - Form 483, 2019-02-13
May, 2022 FDA 483 Saint Bernards Medical Center IRB - Form 483, 2022-05-26
July, 2016 EIR Sina Moainie, M.D. - EIR, 2016-07-18
September, 2021 FDA 483 Sarah E. Zauber, M.D. - Form 483, 2021-09-16
September, 2016 FDA 483 Response Cassandra E. Curtis, M.D. - Form 483R, 2016-10-04
September, 2022 FDA 483 University Of Michigan - IRBMED - Form 483, 2022-09-02
September, 2021 EIR Sarah E. Zauber, M.D. - EIR, 2021-09-16
July, 2015 FDA 483 Med-Mizer, Inc. - Form 483, 2015-07-06
March, 2024 FDA 483 Woodward Pharma Services LLC - Form 483, 2024-03-28
March, 2023 FDA 483 Kathleen N. Moore, M.D. - Form 483, 2023-03-17
May, 2023 FDA 483 Veronique Sebastian, M.D. - Form 483, 2023-05-25
September, 2016 FDA 483 Cassandra E. Curtis, M.D. - Form 483, 2016-09-14
July, 2016 FDA 483 David A. Plager, M.D. - Form 483, 2016-07-27
July, 2016 FDA 483 Sina Moainie, M.D. - Form 483, 2016-07-18
September, 2018 EIR David A. Plager, M.D. - EIR, 2018-09-18
February, 2016 EIR Concentrics Research, LLC - EIR, 2016-02-24
March, 2020 EIR Labcorp Drug Development Inc. - EIR, 2020-03-13
October, 2019 FDA 483 Parham A. Mokri M.D. - Form 483, 2019-10-28
April, 2018 EIR Eli Lilly and Company - EIR, 2018-04-23
December, 2017 EIR Erik A. Imel, M.D. - EIR, 2017-12-14
April, 2018 FDA 483 Eli Lilly and Company - Form 483, 2018-04-23
September, 2016 EIR Cassandra E. Curtis, M.D. - EIR, 2016-09-14
July, 2024 FDA 483 Verdure Sciences, Inc. - Form 483, 2024-07-12
June, 2019 FDA 483 Kathleen N. Moore, M.D. - Form 483, 2019-06-19
August, 2024 FDA 483 Blair M. Brengle, M.D. - Form 483, 2024-08-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more